Skip to content

RESEARCH ON CLINICAL CURATIVE EFFECTS EVALUATION OF KAIXIN JIEYU DECOCTION ON VASCULAR DEPRESSION

RESEARCH ON CLINICAL CURATIVE EFFECTS EVALUATION OF KAIXIN JIEYU DECOCTION ON VASCULAR DEPRESSION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002503
Enrollment
Unknown
Registered
2012-07-13
Start date
2012-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VASCULAR DEPRESSION

Interventions

EXPERIMNETAL GROUP :PHARMACOTHERAPY
CONTROL GROUP :FLUOXETINE HYDROCHLORIDE

Sponsors

CHINESE MEDICAL SCIENCES GUANGAN MEN HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patients have been diagnosed with vascular depression according to "China nervous spirit disease classification scheme anddiagonstic criteria" 3rd edition(ccmd-3), as well as qi deficiencyd anddepression by chinese medicine diagnostic criteria (diagnostics of Chinese medicine) aged from 50 to 75 will be included.

Exclusion criteria

Exclusion criteria: The patient suffer from distuirbance of consciousness, dementia, serious injury of heart, liver andrenal function, serious hemopoietic system diseases, cannot promise adherence of treatment, or have taken antidepressant or other relative medicines by one month has to be excluded.

Design outcomes

Primary

MeasureTime frame
5-hydroxy tryptophan;norepinephrine;

Countries

China

Contacts

Public ContactShijing Huang
gamhsj@126.com+86 13693681458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026